ATAI
ATAI
NASDAQ · Pharmaceuticals

Ataibeckley Inc

$4.22
+0.12 (+2.93%)
As of Jun 24, 1:55 PM ET ·
Analyst Consensus
Strong Buy
20
Analysts
High
Coverage
Buy 19 95%
Hold 1 5%
Sell 0 0%
Price Target
Analyst Price Target +858.3% upside
Low Target $27.58
Average Target $40.44
High Target $50.46
Current Price $4.22
Current
$4.22
Target
$40.44
$27.58 $40.44 avg $50.46
Scenario Analysis
Bear Case
$27.58
553.6%
Low target
Base Case
$40.44
+858.3%
Avg target
Bull Case
$50.46
+1,095.7%
High target
Risk/Reward
2.0x
Balanced
Price in Context
52-Week High
$6.75
-37.5% from high
52-Week Low
$2.00
+111.0% from low
Target vs 52W High
$40.44
+499.1% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 79% $1,330.33 +19.1%
RDY
Dr. Reddy's Laboratories
Sell 44 50% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +24.3%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +32.1%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +41.0%
BMY
Bristol-Myers Squibb Co
Hold 36 39% $174.50 +217.3%
ZTS
Zoetis Inc
Buy 24 58% $209.87 +168.5%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -33.2%